Avita Medical (RCEL) Stock: Buy, Sell, or Hold?
RCEL - Avita Medical, Inc. Common Stock
$15.97
0.79 (5.23%)
▲
5d:
+15.75%
30d:
+36.88%
90d:
+259.77%
WAIT
LOW Confidence
Analysis Updated: Oct 27, 2026 12:00 AM ET
Earnings: Nov 05, 2026
8d
Get Alerted When RCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: RCEL is 10.7% above its trading range ($14.43). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: RCEL is 10.7% above its trading range ($14.43). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: RCEL is currently trading at $15.97, which is considered extended relative to its 30-day fair value range of $11.59 to $14.43. From a valuation perspective, the stock is trading at a discount (Forward PE: -25.2) compared to its historical average (8.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, RCEL is in a strong uptrend. The price is approaching resistance at $16.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: RCEL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $13.58. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RCEL is in a strong uptrend. The price is approaching resistance at $16.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: RCEL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $13.58. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.59 -
$14.43
Company Quality Score
37/100
(SELL)
Options IV Signal
53th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
28.8%
All Signals
- BEARISH: Price significantly overextended (+10.7% above its trading range)
- NEUTRAL: Options fairly priced (IV 53th percentile)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.2%)
- BEARISH: Trading 10.5% above Wall St target ($13.58)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$11.59 -
$14.43
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.09
(13.1%)
Support & Resistance Levels
Support Level
$12.70
Resistance Level
$16.10
Current Trend
Strong Uptrend
Technical data as of
Oct 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.17
Wall Street Target
$13.58
(-10.5%)
Revenue Growth (YoY)
17.8%
Profit Margin
-57.0%
PE vs Historical
-25.2 vs 8.0
CHEAP
Share & Embed Analysis
Last updated: October 27, 2026 3:41 PM ET
Data refreshes hourly during market hours. Next update: 4:41 PM
Data refreshes hourly during market hours. Next update: 4:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$101 | 52 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 48 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 52 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 36 SELL |
